Loading clinical trials...
Loading clinical trials...
Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma
Conditions
Interventions
Percutaneous Laser Ablation (PLA)
Locations
1
United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Start Date
October 19, 2020
Primary Completion Date
October 1, 2026
Completion Date
October 1, 2026
Last Updated
October 8, 2025
NCT06316895
NCT03647358
NCT04785443
NCT07092514
NCT04742608
NCT07447089
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions